ZhuZhou QianJin Pharmaceutical Co Ltd (600479) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ZhuZhou QianJin Pharmaceutical Co Ltd (600479) has a cash flow conversion efficiency ratio of 0.089x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥288.83 Million ≈ $42.27 Million USD) by net assets (CN¥3.24 Billion ≈ $474.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
ZhuZhou QianJin Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how ZhuZhou QianJin Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ZhuZhou QianJin Pharmaceutical Co Ltd (600479) total liabilities for a breakdown of total debt and financial obligations.
ZhuZhou QianJin Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ZhuZhou QianJin Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jiangxi Sanxin Medtec Co Ltd
SHE:300453
|
0.094x |
|
Fujian Raynen Tech Co Ltd
SHG:603933
|
0.038x |
|
Atos SE
PA:ATO
|
-0.308x |
|
African Rainbow Capital Investments Ltd
JSE:AIL
|
0.000x |
|
Compass Pathways Plc
NASDAQ:CMPS
|
-0.926x |
|
Rpmglobal Holdings Ltd
AU:RUL
|
0.126x |
|
Suzhou Tianwo Science and Technology Co Ltd
SHE:002564
|
0.404x |
|
Canadian General Investments Ltd
TO:CGI
|
-0.003x |
Annual Cash Flow Conversion Efficiency for ZhuZhou QianJin Pharmaceutical Co Ltd (2002–2024)
The table below shows the annual cash flow conversion efficiency of ZhuZhou QianJin Pharmaceutical Co Ltd from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of ZhuZhou QianJin Pharmaceutical Co Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.14 Billion ≈ $459.36 Million |
CN¥398.77 Million ≈ $58.35 Million |
0.127x | -13.23% |
| 2023-12-31 | CN¥3.03 Billion ≈ $442.91 Million |
CN¥443.12 Million ≈ $64.84 Million |
0.146x | -43.79% |
| 2022-12-31 | CN¥2.82 Billion ≈ $412.11 Million |
CN¥733.47 Million ≈ $107.33 Million |
0.260x | +44.81% |
| 2021-12-31 | CN¥2.70 Billion ≈ $395.08 Million |
CN¥485.57 Million ≈ $71.05 Million |
0.180x | -8.41% |
| 2020-12-31 | CN¥2.76 Billion ≈ $404.17 Million |
CN¥542.37 Million ≈ $79.37 Million |
0.196x | +232.09% |
| 2019-12-31 | CN¥2.63 Billion ≈ $384.79 Million |
CN¥155.49 Million ≈ $22.75 Million |
0.059x | -62.53% |
| 2018-12-31 | CN¥2.43 Billion ≈ $355.58 Million |
CN¥383.47 Million ≈ $56.11 Million |
0.158x | +24.77% |
| 2017-12-31 | CN¥2.24 Billion ≈ $327.95 Million |
CN¥283.47 Million ≈ $41.48 Million |
0.126x | +87.09% |
| 2016-12-31 | CN¥2.08 Billion ≈ $304.94 Million |
CN¥140.88 Million ≈ $20.62 Million |
0.068x | +96.75% |
| 2015-12-31 | CN¥1.96 Billion ≈ $287.40 Million |
CN¥67.48 Million ≈ $9.88 Million |
0.034x | -74.03% |
| 2014-12-31 | CN¥1.39 Billion ≈ $202.78 Million |
CN¥183.34 Million ≈ $26.83 Million |
0.132x | +15.78% |
| 2013-12-31 | CN¥1.20 Billion ≈ $176.24 Million |
CN¥137.63 Million ≈ $20.14 Million |
0.114x | -38.53% |
| 2012-12-31 | CN¥1.06 Billion ≈ $155.70 Million |
CN¥197.82 Million ≈ $28.95 Million |
0.186x | +718.11% |
| 2011-12-31 | CN¥993.56 Million ≈ $145.39 Million |
CN¥22.58 Million ≈ $3.30 Million |
0.023x | -45.42% |
| 2010-12-31 | CN¥939.81 Million ≈ $137.52 Million |
CN¥39.13 Million ≈ $5.73 Million |
0.042x | -46.14% |
| 2009-12-31 | CN¥951.29 Million ≈ $139.20 Million |
CN¥73.54 Million ≈ $10.76 Million |
0.077x | +81.97% |
| 2008-12-31 | CN¥875.75 Million ≈ $128.15 Million |
CN¥37.20 Million ≈ $5.44 Million |
0.042x | -51.98% |
| 2007-12-31 | CN¥895.95 Million ≈ $131.11 Million |
CN¥79.26 Million ≈ $11.60 Million |
0.088x | -51.42% |
| 2006-12-31 | CN¥659.60 Million ≈ $96.52 Million |
CN¥120.12 Million ≈ $17.58 Million |
0.182x | +41.61% |
| 2005-12-31 | CN¥594.85 Million ≈ $87.05 Million |
CN¥76.50 Million ≈ $11.19 Million |
0.129x | +348.90% |
| 2004-12-31 | CN¥644.15 Million ≈ $94.26 Million |
CN¥18.45 Million ≈ $2.70 Million |
0.029x | -86.90% |
| 2003-12-31 | CN¥233.07 Million ≈ $34.10 Million |
CN¥50.96 Million ≈ $7.46 Million |
0.219x | +567.95% |
| 2002-12-31 | CN¥185.56 Million ≈ $27.15 Million |
CN¥6.07 Million ≈ $888.87K |
0.033x | -- |
About ZhuZhou QianJin Pharmaceutical Co Ltd
ZhuZhou QianJin Pharmaceutical Co.,Ltd researches, develops, produces, and sells traditional Chinese medicines, chemicals and API, and TCM derivatives in China. The company offers TCM products, chemical medicine, derivative products, and hygienic products, including gynaecological and baby nursing, and maternity pad/ maternity package. ZhuZhou QianJin Pharmaceutical Co.,Ltd was founded in 1966 an… Read more